MedGenesis Therapeutix
Victoria · Founded 2005
About MedGenesis Therapeutix
MedGenesis Therapeutix is a privately-held biopharmaceutical company committed to developing and commercializing innovative therapeutics to provide life-enhancing treatments to patients with serious neurologic diseases. MedGenesis Therapeutix is a worldwide leader in Convection Enhanced Delivery (CED), a minimally invasive technique that provides for targeted, local treatment of CNS conditions such as Parkinson's Disease, Epilepsy, Brain Cancer and other severely debilitating diseases of the CNS.
Company Facts
- Founded: 2005
- Legal name: MedGenesis Therapeutix Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Last round: Series Unknown (Jan 2012)
- Website: medgenesis.com
- Phone: +1 250-386-3000
Canonical: https://fsome.com/organization/medgenesis-therapeutix-8439255 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.